![Donald Rose](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Donald Rose
Private Equity Investor chez
Hatteras Venture Partners
Profil
Don Rose is a Venture Partner to Hatteras Venture Partners.
He has extensive experience in launching and building life science startups, most recently as Director of the University of North Carolina’s KickStart program.
At UNC, he helped spin out 80 companies which have gone on to raise over $500M.
While at UNC, he published Research to Revenue: A Practical Guide to University Start-ups (UNC Press, 2016)).
In addition, he’s a Professor of the Practice at UNC’s Kenan-Flagler Business School, teaching entrepreneurship.
Prior to UNC, he held senior leadership roles at a number of life science startups: Metabolon (metabolomics), Deerac Fluidics (nanoliter dispensing), and DataCentric Automation (high-throughput crystallography).
Before that, he was a partner with Catalysta Partners (now Hatteras Venture Partners), where he co-founded Phase Bioscience (NASDAQ: PHAS).
Prior to Catalysta, he was co-founder and VP of Research and Development at Cartesian Technologies, a leader in instrumentation for DNA microarrays and nanoliter dispensing.
Prior to Cartesian, Dr. Rose was a research scientist at Glaxo Wellcome (now GSK) where he developed and promoted a number of technologies in bioanalytical chemistry, combinatorial chemistry and high-throughput screening.
Prior to GW, Dr. Rose developed various aspects of capillary electrophoreses instrumentation at Hewlett-Packard Laboratories.
Dr. Rose received his Ph.D.
in Analytical Chemistry and BS in Nutrition from the University of North Carolina.
He holds six US patents and has published eight papers, and two book chapters.
Postes actifs de Donald Rose
| Sociétés | Poste | Début |
|---|---|---|
Hatteras Venture Partners
 Hatteras Venture Partners Investment ManagersFinance Hatteras Venture Partners invests in companies located in the United States. The firm targets companies operating in the fields of biopharmaceuticals, medical devices, diagnostics, healthcare IT and human medicine. It provides financing for seed and early stage capital requirements and also makes co-investments. | Private Equity Investor | 01/11/2019 |
Anciens postes connus de Donald Rose
| Sociétés | Poste | Fin |
|---|---|---|
Equiti P.B.C.
 Equiti P.B.C. Internet Software/ServicesTechnology Services Operates as block chain-based gaming platform for purchase, distribution and exchange of digital games | Directeur Général | 01/09/2020 |
Glaxo, Inc. | Corporate Officer/Principal | - |
| HP INC. | Corporate Officer/Principal | - |
Cartesian Technologies, Inc.
 Cartesian Technologies, Inc. Medical SpecialtiesHealth Technology Manufactures systems for precision microscale liquid handling and automation | Corporate Officer/Principal | - |
| PHASEBIO PHARMACEUTICALS, INC. | Corporate Officer/Principal | - |
Formation de Donald Rose
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
31
Relations au 1er degré
7
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 7 |
|---|---|
HP, Inc.
 HP, Inc. Information Technology ServicesTechnology Services Operates as a technology company that sells laptops, pc desktops, printers and accessories through online | Technology Services |
PhaseBio Pharmaceuticals, Inc.
 PhaseBio Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Engages in development and commercialization of novel therapies for cardiovascular diseases | Health Technology |
Cartesian Technologies, Inc.
Cartesian Technologies, Inc. Medical SpecialtiesHealth Technology Manufactures systems for precision microscale liquid handling and automation | Health Technology |
Hatteras Venture Partners
Hatteras Venture Partners Investment ManagersFinance Hatteras Venture Partners invests in companies located in the United States. The firm targets companies operating in the fields of biopharmaceuticals, medical devices, diagnostics, healthcare IT and human medicine. It provides financing for seed and early stage capital requirements and also makes co-investments. | Finance |
Glaxo, Inc. | |
The University of North Carolina at Charlotte
 The University of North Carolina at Charlotte Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Equiti P.B.C.
Equiti P.B.C. Internet Software/ServicesTechnology Services Operates as block chain-based gaming platform for purchase, distribution and exchange of digital games | Technology Services |
